UC, UC Health to launch Phase 3 clinical trial for COVID-19 vaccine
Vaccine uses a genetic code to produce proteins that may generate protective antibodies
Researchers at the University of Cincinnati and UC Health will host a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19, the respiratory illness caused by the novel coronavirus SARS-CoV-2.
UC is one of approximately 90 sites across the United States selected for the study, which will administer the vaccine candidate mRNA-1273 to volunteer participants and monitor its efficacy in eliciting an immune response that provides protection from COVID-19. The National Institute of Allergy and Infectious Diseases, (NIAID), part of the National Institutes of Health, is funding the study.
“UC was chosen because we have a proven track record of high-quality research and are the number one site in the NIAID-funded, AIDS Clinical Trials Group in the U.S. We are proud to bring leading-edge research to Cincinnati so that we can help our community battle the COVID-19 pandemic and be part of the solution,” said Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases at the UC College of Medicine and a UC Health physician.
Fichtenbaum is co-investigator of the study and will serve as medical director.
Read the full story here.
Featured photo of COVID-19 vials by Colleen Kelley/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
UC research shows effectiveness of ointment that kills...
December 1, 2021
Research from the University of Cincinnati College of Medicine shows that use of a topical drug, called AB569, a combination of acidified nitrite and EDTA (or ethylenediaminetetraacetic acid) promotes killing of antibiotic-resistant bacteria while enhancing the healing of wounds in a variety of burn injuries. The study was published in the journal Infection and Immunity.
Dallas Morning News: Families separated at the U.S.-Mexico...
November 30, 2021
New research on the forcible separation of families at the U.S.-Mexico border, shows that many parents and children showed long-term, serious mental health disorders such as post-traumatic stress disorder (PTSD), anxiety and depression. In a story on the study, the Dallas Morning News interviewed several expert sources, including Maria Espinola, PsyD, assistant professor in the Department of Psychiatry and Behavioral Neuroscience at the UC College of Medicine.
Survey: ‘Tweens’ increased media use during the 2020 pandemic...
November 30, 2021
A new study by UC researcher Nancy Jennings shows how media use for "tweens" changed during COVID-19 lockdowns